Medoro Resources Receives Listing Approval
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN
THE UNITED STATES/
TORONTO, Feb. 13 /CNW/ - Medoro Resources Ltd. (TSX-V/AIM: MRL) announced
today that the TSX Venture Exchange (TSXV) has provided its conditional
listing approval for the previously announced offering of 100 million common
shares at $0.10 per share for gross proceeds of $10 million. Medoro and GMP
Securities L.P. have agreed not to issue any additional shares pursuant to the
previously announced option as the TSXV required that the Medoro common shares
to be issued pursuant to the previously announced option be priced at an
amount higher than the $0.10 per share offering price.
The offering will be completed with GMP acting as agent on a
'best-efforts' private placement basis and subject to the parties executing a
formal agency agreement. The company has also applied to have the shares
admitted to trading on the Alternative Investment Market (AIM) of the London
Stock Exchange plc.
The financing is subject to final regulatory approval and is expected to
close on or before February 28, 2006. All shares issued will be subject to a
four-month hold period.
The funds will be used for general corporate and working capital
purposes, which may include costs associated with identifying potential
acquisitions.
Medoro Resources is a gold exploration and development company focused on
gold opportunities in Italy and elsewhere. In addition to its financial
assets, the company has a 30% interest in the Monte Ollasteddu gold prospect
in Italy. For further information, please visit the company's website at
www.medororesources.com.
THE TSX VENTURE EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT
RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE
The securities being offered have not been, nor will they be, registered
under the United States Securities Act of 1933, as amended, and may not be
offered or sold within the United States or to, or for the account or benefit
of, U.S.persons absent U.S. registration or an applicable exemption from U.S.
registration requirements. This release does not constitute an offer for sale
of securities in the United States.
For further information: Peter Volk, Secretary, (416) 603-4653,
pvolk(at)medororesources.com
(MRL.)
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.